Basement Membrane Type IV Collagen Degradation: Evidence for the Involvement of a Proteolytic Cascade Independent of Metalloproteinases

Cancer Research

Volumn 50, Issue 18, 1990, Pages 5997-6001

  MacKay, A R ^a   Corbitt, R H ^a   Hartzler, J L ^a   Thorgeirsson, U P ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; PLASMIN; PLASMINOGEN ACTIVATOR; COLLAGEN; METALLOPROTEINASE;

ANIMAL CELL; ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; CELL CULTURE; CYTOCHEMISTRY; CYTOLOGY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; METABOLISM; NEOPLASM; PHYSIOLOGY;

BASEMENT MEMBRANE; COLLAGEN; HUMAN; METALLOENDOPEPTIDASES; NEOPLASMS; PLASMIN; PLASMINOGEN ACTIVATORS;

EID: 0025193320     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Salo, T., Liotta, L. A., Keski-Oja, J., Turpeenniemi-Hujanen, T., and Tryggvason, K. Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells; role in metastasis. Int. J. Cancer, 30: 669–673, 1982.
2. Carlsen, S. A., Ramshaw, I. A., and Warrington, R. C. Involvement of plasminogen activator with tumor metastases in a rat model. Cancer Res., 44: 3012–3016, 1984.
3. Reich, R., Thompson, E. W., Iwamoto, Y., Martin, G. R., Deason, J. R., Fuller, G. C., and Miskin, R. Effects of inhibitors of plasminogen activators, serine proteases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res., 48: 3307–3312, 1988.
4. Mignatti, P., Robbins, E., and Rifkin, D. B. Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell, 47: 487–498, 1986.
5. Thorgeirsson, U. P., Liotta, L. A., Kalebic, T., Margulies, I. M., Thomas, K., Rios-Candelore, M., and Russo, R. G. Effect of natural proteinase inhibitors and a chemoattractant on tumor cell invasion in-vitro. J. Natl. Cancer Inst., 69: 1049–1054, 1982.
6. Raymond, N. G., and Kellen, J. A. The role of plasminogen activators in metastasis. Med. Hypoth., 10: 291–293, 1983.
7. Liotta, L. A., Goldfarb, R. H., Brundage, R., Siegal, G. P., Terranova, V., and Garbisa, S. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res., 41: 4629–4636, 1981.
8. Paranjpe, M., Engel, L., Young, N., and Liotta, L. A. Activation of human breast carcinoma collagenase through plasminogen activator. Life Sci., 26: 1223–1231, 1980.
9. Werb, Z., Mainardi, C. L., Vater, C. A., and Harris, E. D., Jr. Endogenous activation of latent collagenase by rheumatoid synovial cells-evidence for a role of plasminogen activator. N. Engl. J. Med., 296: 1017–1023, 1977.
10. He, C., Wilhelm, S. M., Pentland, A. P., Manner, B. L., Grant, G. A., Eisen, A. Z., and Goldberg, G. I. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc. Natl. Acad. Sci. USA, 86: 2632–2636, 1989.
11. Wang, B. S., McLoughlin, G. A., Richie, J. P., and Mannick, J. A. Correlation of the production of plasminogen activator with tumor metastasis in B16 melanoma cell lines. Cancer Res., 40: 288–292, 1980.
12. Pauli, B. U., Arsenis, C., Hohberger, L. H., and Schwarz, D. E. Connective tissue degradation by invasive rat bladder carcinomas: action of nonspecific proteinases on collagenous matrices. Cancer Res., 46: 2005–2012, 1986.
13. Burleigh, M. C. Degradation of collagen by non-specific proteinases. In: A. J. Barrett (ed.), Proteinases in Mammalian Cells and Tissues, pp. 285–309. Amsterdam: Elsevier/North-Holland Biomedical Press, 1979.
14. Weiss, J. B., Sedowofia, K., and Jones, C. Collagen degradation: a defended multi-enzyme system. In: A. Vidik and J. Vuust (eds.), Biology of Collagen, pp, 113–134. New York: Academic Press, 1980.
15. Barrett, A. J. Which enzymes degrade cartilage matrix? In: J. T. Dingle and J. L. Gordon (eds.). Cellular Interactions, pp, 185–194. Amsterdam: Elsevier/North-Holland Biomedical Press, 1981.
16. Pauli, B. U., Schwartz, D. E., Thonar, E. J. M., and Kuettner, K. E. Tumor invasion of host extracellular matrix. Cancer Metastasis Rev., 2: 129–152, 1983.
17. Birkedal-Hansen, H., and Dano, K. A sensitive collagenase assay using [3H] collagen labeled by reaction with pyridoxal phosphate and (3HJborohydride. Anal. Biochem., 115: 18–26, 1981.
18. Hantai, D., Rao, J. S., Kahler, C., and Festoff, B. W. Decrease in plasminogen activator correlates with synapse elimination during neonatal development of mouse skeletal muscle. Neurobiology, 86: 362–366, 1989.
19. Dolz, R., Engel, J., and Kuhn, K. Folding of collagen IV. Eur. J. Biochem., 178: 357–366, 1988.
20. Privalov, P. L., Tiktopulo, E. I., and Tischenko, V. M. Stability and mobility of the collagen structure. J. Mol. Biol., 127: 203–216, 1979.
21. Heussen, C., and Dowdle, E. B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem., 102: 196–202, 1980.
22. Birkedal-Hansen, H., and Taylor, R. E. Detergent-activation of latent collagenase and resolution of its component molecules. Biochem. Biophys. Res. Commun., 107: 1173–1178, 1982.
23. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680–685, 1970.
24. Stetler-Stevenson, W. G., Krutsch, H. C., Wacher, M. P., Margulies, I. M., and Liotta, L. A. The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organ-omercurial activation. J. Biol. Chem., 264: 1353–1356, 1989.
25. Davies, G. E., and Martin, B. M. A latent A/r 94,000 gelatin-degrading metalloproteinase induced during differentiation of HL-60 promyelocyte leukemia cells: a member of the collagenase family of enzymes. Cancer Res., 50: 1113–1120, 1990.
26. Hantai, D., and Festoff, B. W. Degradation of muscle basement membrane zone by locally generated plasmin. Exp. Neurol., 95: 44–45, 1987.
27. Collier, I. E., Wilhelm, S. M., Eisen, A. Z., Manner, B. L., Grant, G. A., Seltzer, J. L., Kronenberger, A., He, C., Bauer, E. A., and Goldberg, G. I. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloproteinase capable of degrading basement membrane collagen. J. Biol. Chem., 263: 6579–6587, 1988.
28. Wilhelm, S. M., Collier, I. E., Manner, B. L., Eisen, A. Z., Grant, G. A., and Goldberg, G. I. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem., 264: 17213–17221, 1989.
29. Ballin, M., Gomez, D. E., Sinha, C. C., and Thorgeirsson, U. P. ras Oncogene mediated induction of a 92kDa metalloproteinase; strong correlation with the malignant phenotype. Biochem. Biophys. Res. Commun., 154: 832–838, 1988.
30. Hayashi, T., Cunan-Patel, S., and Prockop, D. J. Thermal stability of the triple helix of type I procollagen and collagen. Precautions for minimizing ultraviolet damage to proteins during circular dichroism studies. Biochemistry, 22: 354–358, 1983.
31. Harris, E. D., and Krane, S. M. Collagenases (first of three pans). N. Engl. J. Med., 291: 557–563, 1974.
32. Burtin, P., and Fondaneche, M.-C. Receptor for plasmin on human carcinoma cells. J. Natl. Cancer Inst., 80: 762–765, 1988.
33. Plow, E. F., Freaney, D. E., Plescia, J., and Miles, L. A. The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type. J. Cell Biol., 103: 2411–2420, 1986.
34. Burtin, P., Cnavanel, G., Andre-Bougaran, J., and Gentile, A. The plasmin system in human adenocarcinomas and their metastases. A comparative immunofluorescence study. Int. J. Cancer, 39: 170–178, 1987.
35. Skriver, L., Larsson, L.-I., Kielberg, V., Nielsen, L. S., Andresen, P. B., Kristensen, P. and Dano, K. Immunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma. J. Cell Biol., 99: 752–757, 1984.
36. Bland, V., Karlan, B. Y., Zurawski, V. R., Jr., and Littlefield, B. A. Simultaneous stimulation of urokinase and tissue-type plasminogen activators by phorbol esters in human ovarian carcinoma cells. J Cell Biol., 138: 106–114, 1989.
37. Pourreau-Schneider, N., Delori, P., Boutiere, B., Arnoux, D., George, F., Sampol, J., and Marin, M. Modulation of plasminogen activator systems by matrix components in two breast cancer cell lines: MCF-7 and MDA-MB-231. J. Natl. Cancer Inst., 81: 259–266, 1989.
38. Liotta, L. A., Abe, S., Robey, P. G., and Martin, G. R. Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor. Proc. Natl. Acad. Sci. USA, 76: 2268–2272, 1979.
39. Stetler-Stevenson, W. G., Krutzsch, H. C., and Liotta, L. A. Tissue inhibitor of metallproteinase (TIMP-2). J. Biol. Chem., 264: 17374–17378, 1989.
40. Murphy, G., Reynolds, J. J., and Werb, Z. Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture: stimulation by 12–0-tetradecanoylphorbol 13-acetate and interleukin 1 in parallel with collagenase. J. Biol. Chem., 260: 3079–3083, 1985.
41. Henon, G. S., Banda, M. G., Clark, E. J., Gavrilovic, J., and Werb, Z. Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J. Biol. Chem., 261: 2814–2818, 1986.
42. Herron, G. S., Werb, Z., Dwyer, K., and Banda, M. J. Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procol-lagenase and prostromelysin exceeds expression of proteolytic activity. J. Biol. Chem., 261: 2810–2813, 1986.
43. Gavrilovic, J., Hembry, R. M., Reynolds, J. J., and Murphy, G. Tissue inhibitor of metalloproteinases (TIMP) regulates extracellular type I collagen degradation by chondrocytes and endothelial cells. J. Cell Sci., 87: 357–362, 1987.
44. Birkedal-Hansen, H., Birkedal-Hansen, B., Windsor, L. J., Lin, H.Y., Taylor, R. E., and Moore, W. G. I. Use of inhibitory (anti-catalytic) antibodies to study extracellular proteolysis. Immun. Invest., 18: 211–224, 1989.
45. Tryggvason, K., Philajanaemi, T., and Salo, T. Studies on the molecular composition and degradation of type IV procollagen. Ciba Found. Symp., 108: 117–129, 1984.
46. Pipoly, D. J., and Crouch, E. C. Degradation of native type IV procollagen by human neutrophil elastase. Implications for leukocyte mediated degradation of basement membranes. Biochemistry, 26: 5748–5754, 1987.
47. Davies, M., Barret, A. J., Travis, J., Sanders, E., and Coles, G. A. The degradation of human glomerular basement membrane with purified proteases. Evidence for the pathogenic role of the polymorphonuclear leukocyte in glomerulonephritis. Clin. Sci. Mol. Med., 54: 233–240, 1979.
48. Wilhelm, S. M., Collier, I. E., Kronenberger, A., Eisen, A., Manner, B. L., Grant, G. A., Bauer, E. A., and Goldberg, G. I. Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells. Proc. Natl. Acad. Sci. USA, 84: 6725–6729, 1987.